Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 13, 2011, Pages 9567-9572

  Rocha, Eduardo M ^a,b   Di Pasquale, Giovanni ^a   Riveros, Paola Perez ^a   Quinn, Kathrina ^a   Handelman, Beverly ^a   Chiorini, John A ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; LUCIFERASE; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; LACRIMATION; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; ADENO ASSOCIATED VIRUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; ENZYME IMMUNOASSAY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; LACRIMAL APPARATUS; LUMINESCENCE; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; IMMUNOENZYME TECHNIQUES; LACRIMAL APPARATUS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL TROPISM;

EID: 84857230493     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8171     Document Type: Article

References (26)

1. Montés-Micó R, Cerviño A, Ferrer-Blasco T, García-Lázaro S, Madrid-Costa D. The tear film and the optical quality of the eye. Ocul Surf. 2010;8:185-192.
2. Scherz W, Dohlman CH. Is the lacrimal gland dispensable? Keratoconjunctivitis sicca after lacrimal gland removal. Arch Ophthalmol. 1975;93:281-283.
3. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:93-107.
4. Sullivan DA, Wickham LA, Rocha EM, et al. Androgens and dry eye in Sjogren's syndrome. Ann N Y Acad Sci. 1999;876:312-324.
5. Garcia-Carrasco M, Fuentes-Alexandro S, Escarcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sjogren's syndrome. Arch Med Res. 2006;37:921-932.
6. Tzioufas AG, Tsonis J, Moutsopoulos HM. Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation. 2008;15:37-45.
7. Trousdale MD, Zhu Z, Stevenson D, Schechter JE, Ritter T, Mircheff AK. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J Autoimmune Dis. 2005;2:6-12.
8. Thomas PB, Samant DM, Selvam S, et al. Adeno-associated virusmediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci. 2010;51:5137-5144.
9. Hodges RR, Raddassi I, Zoukhri D, Toker A, Kazlauskas A, Dartt DA. Effect of overexpression of constitutively active PKCalpha on rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci. 2004;45:3974-3981.
10. Sharma A, Tovey J, Ghosh A, Mohan R. AAV serotype influences gene transfer in corneal stroma in vivo. Exp Eye Res. 2010;91:440-448.
11. Kaludov N, Handelman B, Chiorini JA. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther. 2002;13:1235-1243.
12. Zoukhri D, Macari E, Kublin CL. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res 2007;84:894-904.
13. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, da Silveira LA, Toda I. Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol. 1998;438:11-42.
14. Voutetakis A, Zheng C, Mineshiba F, et al. Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther. 2007;18:142-150.
15. Doughty MJ, Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthalmic Physiol Opt. 2009;29:573-583.
16. Ramos-Casals M, Tzioufas A, Stone J, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304: 452-460.
17. Asbell PA, Spiegel S. Ophthalmologist perceptions regarding treatment of moderate-to-severe dry eye: results of a physician survey. Eye Contact Lens. 2010;36:33-38.
18. Baum BJ, Zheng C, Alevizos I, et al. Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol. 2010;46:4-8.
19. Mohan RR, Schultz GS, Hong JW, Wilson SE. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp Eye Res. 2003;76:373-383.
20. Gloor BP, Rokos L, Kaldarar-Pedotti S. Cell cycle time and life-span of cells in the mouse eye. Measurements during the postfetal period using repeated 3H-thymidine injections. Dev Ophthalmol. 1985;12:70-129.
21. Goncalves MA. Adeno-associated virus: from defective virus to effective vector. Virol J. 2005;2:43-60.
22. Lavoie TN, Lee BH, Nguyen CQ. Current concepts: mouse models of Sjögren's syndrome. J Biomed Biotechnol. 2011;2011:549107.
23. Zhu Z, Stevenson D, Schechter JE, et al. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis. Cornea. 2003;22:343-351.
24. O'Connell BC, Zheng C, Jacobson-Kram D, Baum BJ. Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats. J Oral Pathol Med. 2003;32:414-421.
25. Katano H, Kok MR, Cotrim AP, et al. Enhanced transduction of mouse salivary glands with AAV5-based vectors. Gene Ther. 2006; 13:594-601.
26. Zhu Z, Stevenson D, Schechter JE, et al. Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis. Invest Ophthalmol Vis Sci. 2004;45:1375-1381.